Article info
PDFClinical trial
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
- Correspondence to Anne Sophie V M van den Heerik, Radiotherapy, Leiden Universitair Medisch Centrum, 2333 ZA Leiden, Zuid-Holland, Netherlands; a.v.m.van_den_heerik{at}lumc.nl
Citation
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
Publication history
- Accepted August 17, 2020
- First published October 12, 2020.
Article Versions
- Previous version (12 October 2020).
- You are currently viewing a Previous version of this article (20 October 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.